27th February 2024

Confidant Classes

for LAW | CLAT | JUDICIARY

Home | Edu NEWS | Free COVID19 vaccination in India

Free COVID19 vaccination in India

The free vaccine will be provided to three billion people of frontline and healthcare workers in the first phase of vaccination, Health Minister Harsh Vardhan said on Saturday while providing an update on dry vaccination in the country conducted nationwide in 125 districts at 285 sites.

  • The minister added that the details of the priority beneficiaries of 27 million million, those over 50 and the minors with comorbidities are also being finalized.
  • Speaking of the reluctance to vaccinate, the minister said it was not a new phenomenon. Calling on the Co-WIN digital platform, reconverted from the e-VIN platform to be a true game changer, the minister also explained that this platform will provide real-time information on vaccine stocks , its storage temperature and individualized monitoring of COVID beneficiaries. -19 vaccine.
  • He added that this platform will help program managers at all levels through automated assignment of sessions to pre-enrolled recipients, their verification, and generation of a digital certificate after successfully completing the schedule vaccination.
  • The first COVID-19 vaccine developed locally in India, Covaxin, has been recommended for “restricted use in emergency situations, subject to multiple regulatory conditions” by the Central Committee of Experts on Subject Standard Medicines (SEC) Control Organization ( ), here on Saturday.
  • The Comptroller General of Medicines (DCGI) will take a final call to approve the deployment of the vaccine in the country. The recommendation was made after a two-day meeting in which the expert group sent Covishield, the vaccine developed by AstraZeneca and the University of Oxford, and manufactured by the Serum Institute of India in Pune. (SII) for approval by DCGI on Friday.
  • The Health Ministry, in its statement, said that the SEC has made three recommendations for consideration and final decision by the Comptroller General of Medicines of India (DGCI).
  • This includes granting an authorization for restricted emergency use of the vaccine, subject to multiple regulatory conditions in the Serum Institute of India, granting an authorization for restricted use in an emergency situation in the public interest as a precaution abundant, in clinical trial mode, particularly in the context of infection by mutant strains at and authorization to conduct phase 3 clinical trials at Cadila Healthcare.
  • Meanwhile, the Indian Council for Medical Research (ICMR) said on Saturday that it had successfully isolated and cultured the British variant of Sars-CoV-2, adding that no other country had so far reported successful isolation and culturing of the variant, according to ICMR.

“Scientists at the ICMR (National Institute of Virology NIV) used Vero cell lines to grow the variant of the virus in the ,”

said the ICMR.

“UNITED KINGDOM. The virus variant, with all signature changes, is now successfully isolated and cultured from clinical samples collected from returnees in the UK,”

ICMR noted in its tweet.
  • India has so far reported 29 cases of the new variant of the coronavirus.
Delhi University 5 Year Law Programs Registration Begins

Delhi University 5 Year Law Programs Registration Begins

Delhi University has started the registration process for 5 year programs. Candidates applying for the 5-year law programs can…
Read More
Bar Council of India proposes to hold CLAT and declares NLU Consortium a non-statutory body

Bar Council of India proposes to hold CLAT and declares NLU Consortium a non-statutory body

The Bar Council of India, in a supplementary affidavit filed before the Delhi High Court, proposed to conduct the Common…
Read More
DU UG 2023 Admissions Process Expected to Begin End of May

DU UG 2023 Admissions Process Expected to Begin End of May

Admissions for undergraduate and graduate programs will be by CSAS (UG) 2023 and CSAS (PG) 2023. Delhi University plans to…
Read More
CUET UG 2023 Participating Universities | Central University of Karnataka

CUET UG 2023 Participating Universities | Central University of Karnataka

The Central Karnataka University will start admission for its undergraduate programs from May 21 this year. Admission to these UG…
Read More
AIBE XVII 2023 results published

AIBE XVII 2023 results published

AIBE XVII Result: Candidates who have taken the exam can now check their result on the AIBE website: allindiabarexamination.com. AIVE…
Read More
CUET PG 2023 | Six universities join the CUET PG

CUET PG 2023 | Six universities join the CUET PG

CUET PG 2023: Interested and eligible candidates can apply until May 5 on the official website: cuet.nta.nic.in. The CUET PG…
Read More
AIBE XVII (17) 2023 result

AIBE XVII (17) 2023 result

Once released, candidates who have taken the AIBE XVII(17) 2023 exam will be able to check their score on the…
Read More
CUET UG 2023 Participating Universities |  Central University of Haryana

CUET UG 2023 Participating Universities |  Central University of Haryana

The university currently has eight schools and 34 departments that offers science and humanities programs. CUET-2023-Preparation CUET UG 2023: The…
Read More
CUET UG 2023 Participating Universities: BHU

CUET UG 2023 Participating Universities: BHU

CUET UG 2023: After Delhi University, BHU received the most applications among central universities. Here is everything you need to…
Read More
CUET PG 2023 to be held June 5-12

CUET PG 2023 to be held June 5-12

CUET PG 2023: Exams will be held daily from June 5-12, i.e. June 5, 6, 7, 8, 9, 10, 11,…
Read More

About Post Author